Running title: AKT promotes oxidative stress in galactose culture AKT promotes oxidative stress in galactose culture 2 ABSTRACT Oncogenes can generate metabolic vulnerabilities in cancer cells. Here, we tested how AKT and MYC affect the ability of cells to shift between respiration and glycolysis.
INTRODUCTION
Many cancers preferentially use glycolysis for survival and proliferation, even in the presence of oxygen, a phenomenon known as aerobic glycolysis or the Warburg effect. Increased glycolytic activity is thought to help satisfy the rapacious demands of highly proliferative cancer cells for biosynthetic precursors including lipids, proteins, and nucleic acids. However, this altered metabolism can leave tumors vulnerable to metabolic disruptions such as starvation of substrates including glucose, asparagine, glutamine, methionine, serine, and others (1) (2) (3) (4) (5) (6) (7) . Therefore, understanding the interplay between oncogenes and metabolism is essential to understand how to design therapeutic strategies targeting tumor metabolism (8, 9) .
The altered metabolism of tumor cells has been directly linked to the same oncogenes that drive tumorigenesis. In breast cancer, both the PI3K/AKT signaling pathway and the transcription factor MYC are frequently hyperactivated (10) . Deregulated PI3K/AKT signaling can result from multiple mechanisms including PIK3CA mutation, PTEN loss/mutation, or high AKT3 expression. Hyperactivated PI3K/AKT signaling, which is prominent in the luminal subtype of breast cancer, results in increased glycolytic flux by altering the localization and activity of glycolytic enzymes including glucose transporters, hexokinase, and phosphofructokinase (11) . The oncogenic transcription factor MYC is typically hyperactivated by high-level DNA amplification, especially in the basal subtype of breast cancer. Like AKT, MYC also exerts broad effects on the metabolism of tumor cells including roles in glycolysis, glutamine metabolism, nucleotide biosynthesis, and other metabolic processes (12) . However, although both AKT and MYC AKT promotes oxidative stress in galactose culture 4 promote aerobic glycolysis, these oncogenes can exert differential effects on metabolism in prostate cancer and pre-B cells (13, 14) . The galactose culture system is a classic technique for shifting the metabolism of mammalian cells from glycolysis to aerobic respiration. In glucose-containing media, mammalian cells can utilize both glycolysis and oxidative phosphorylation (OXPHOS) to generate ATP. However, when galactose is substituted for glucose, cells must rely on OXPHOS for energy generation. Most mammalian cells exhibit a flexible metabolic state that can dynamically shift between glycolysis and OXPHOS. Because galactose culture forces oxidative metabolism, it has proved useful in the identification of inborn errors of metabolism (15, 16) , drugs that redirect metabolism to glycolysis (17) , genes essential for OXPHOS (18) , and the role of aerobic glycolysis in T cell effector functions (19) . However, to our knowledge, the galactose culture system has not been used to investigate the metabolic vulnerabilities induced by oncogenes.
Here, we report that non-tumorigenic, immortalized mammary epithelial cells expressing constitutively active AKT undergo rapid cell death when switched from glucose to galactose culture. In contrast, cells expressing either RFP (i.e., negative control) or MYC readily proliferated in galactose. Cell death in AKT-expressing cells was, however, short-lived, and cells expressing AKT recommenced cell growth after ~15 days in galactose culture. To understand the differential phenotype of AKT-expressing cells, we performed metabolomic and proteomic analyses using mass spectrometry and found evidence that AKT-expressing cells in galactose were dying due to oxidative stress. We AKT promotes oxidative stress in galactose culture 5 therefore used the reactive oxygen species (ROS) scavenger catalase to validate that ROS were required for galactose-induced death of AKT-expressing cells. Importantly, we also tested breast cancer cell lines with constitutively active PI3K/AKT signaling and found that these cells also exhibited cell death in galactose culture and were also rescued by catalase. Taken together, our multi-omic analysis has identified a metabolic statedependent lethality, namely the reduced ability of cells with constitutive activation of PI3K/AKT to switch between glycolysis and respiration.
RESULTS

AKT but not MYC temporarily induces cell death in oxidative culture.
To investigate the effect of oncogenes on the ability of human cells to survive and proliferate in oxidative culture, we first expressed either constitutively active AKT (i.e., myristoylated, or mAKT), the transcription factor MYC, or the negative control red fluorescent protein (RFP) in immortalized but non-tumorigenic MCF-10A human mammary epithelial cells. We then switched these cells from normal glucose culture to galactose culture, which forces mammalian cells to rely on oxidative phosphorylation rather the glycolysis (15) . Following the switch to galactose culture, cells expressing either RFP or MYC grew ~2-fold slower than in glucose culture but did not exhibit significant cell death ( Fig. 1A) . In contrast, cells expressing mAKT exhibited significant cell death and declining cell numbers for three passages in galactose culture. Interestingly, mAKTexpressing cells reversed this phenotype after three passages (~15 days) and recommenced proliferation in galactose culture. However, at later passages, mAKTexpressing cells still exhibited significantly slower growth in galactose relative to glucose than did RFP-or MYC-expressing cells ( Fig. 1B ). Next, using liquid chromatographymass spectrometry (LC-MS) metabolomics, we assessed the effect of galactose culture on aerobic glycolysis by measuring the intracellular concentration of lactate. We found that galactose culture significantly reduced the intracellular concentration of lactate at both short (24 h) and long (~5 passages or ~25 days) for all three cell types (Fig. 1C) .
Notably, mAKT-expressing cells in glucose exhibited the highest intracellular concentrations of lactate, consistent with reports that mAKT can increase aerobic glycolysis (13, 20) . Next, we tested whether galactose culture affected the expression of AKT promotes oxidative stress in galactose culture 7 the exogenous oncogenes. After 24 h, galactose culture induced a slight decrease in expression of AKT and phospho-serine-473 AKT, but expression was restored at longer times (~5 passages) ( Fig. 1D ). Conversely, expression of MYC was unaffected by galactose culture. Taken together, these data demonstrate that the oncogenes mAKT and MYC exert opposite effects on the ability of non-tumorigenic MCF-10A cells to proliferate in oxidative culture conditions (i.e., galactose) at short times (< 3 passages) but that cells expressing either oncogene can proliferate in oxidative culture at longer times.
mAKT-expressing cells exhibit extensive metabolic adaptation in galactose culture.
To elucidate the metabolic mechanisms regulating the differential phenotypes of RFP-, mAKT-, and MYC-expressing cells in galactose culture, we profiled cells using stable isotope tracing LC-MS metabolomics (Supp. Fig. S1 ). Because cells in galactose culture upregulate glutamine anaplerosis (17, 21) , we first labeled cells with [U-13 C]-Lglutamine for 24 h in either glucose, short-term galactose culture (24 h), or long-term galactose culture (~5 passages) and followed by LC-MS metabolomics (Supp. Fig. S2A and Supp. Table S1 ). Relative to RFP-expressing cells, mAKT-but not MYC-expressing cells cultured in glucose exhibited an increased percentage of M0 isotopomers for the TCA cycle intermediates citrate/isocitrate, aconitate, α-ketoglutarate, succinate, fumarate, and malate ( Fig. 2A-B and Supp. Table S2 ). Examining the fractional incorporation of 13 C, we found that mAKTexpressing cells exhibited a small but significant reduction in 13 AKT promotes oxidative stress in galactose culture 9 incorporation in glutamate, alanine, citrate/isocitrate, and fumarate, and decreased 13 C fractional incorporation into GSH and GSSG. Overall, the changes in galactose-derived 13 C fractional incorporation for mAKT-expressing cells were much greater than for RFPor MYC-expressing cells. Taken together, this demonstrates that AKT-expressing cells exhibited significantly larger adaptations to galactose culture than do RFP-or MYCexpressing cells, consistent with the observation that AKT-expressing cells initially die in galactose culture before recommencing proliferation.
Short-term galactose culture increases glutathione metabolism in mAKTexpressing cells.
To further understand the metabolic profile that occurs in MCF-10A cells expressing oncogenes when switched from glucose to galactose, we next analyzed metabolite pool sizes (Supp . Table S3 ). Unsupervised hierarchical clustering of metabolite pool sizes segregated samples based on the culture condition (glucose, shortterm galactose, and long-term galactose culture) rather than by oncogene (RFP, mAKT, and MYC) ( Fig. 3A) . No obvious grouping of functionally related metabolites was apparent from the hierarchical clustering of metabolites. Therefore, to identify metabolic pathways affected by galactose culture in each cell type, we employed Metabolite Set Enrichment Analysis (MSEA) (13, 22, 23) . First, we analyzed the relative enrichment of all KEGG pathways comparing short-term galactose to glucose culture. To identify differentially enriched pathways, we plotted the MSEA results on a volcano-style plot (Fig. 3B ). This analysis revealed that glutathione metabolism was significantly enriched in short-term galactose mAKT-but not RFP-or MYC-expressing cells ( Fig. 3C and Supp. Fig. S4A ,C).
Next, we conducted a similar analysis comparing metabolite pool sizes in short-term and long-term galactose cultured cells. Again, we found that glutathione metabolism was significantly enriched in short-term galactose mAKT-but not RFP-or MYC-expressing cells ( Fig. 3D -E and Supp. Fig. S4B,D) . Taken together, this metabolite set enrichment analysis suggests that glutathione metabolism is specifically upregulated in mAKTexpressing cells when initially switched to galactose culture.
Proteomic analysis reveals enriched nonsense-mediated mRNA decay (NMD) in mAKT-expressing cells in short-term galactose culture.
Next, to further characterize the mechanisms underlying the differential phenotype of mAKT-expressing cells in galactose culture, we performed label-free quantitative LC-MS proteomics. We analyzed two independent biological experiments of MCF-10A cells expressing either RFP, mAKT, or MYC cultured in glucose, short-term galactose, and long-term galactose culture. Across both experiments, we identified and quantified 2,460 proteins, 1,356 of which were quantified in both biological replicates ( Fig. 4A and Supp. Table S4 ). To identify global differences between samples, we conducted principal component analysis (PCA) using the proteins identified in both biological replicates. PCA revealed a clear separation across samples and consistent trends across the two experiments. Notably, in both replicates, short-term galactose culture induced a positive shift on PC1 (48.4% of variation for Experiment 1) for all cell types ( Fig. 4B and Supp. Fig.   S5A ). Long-term galactose culture, in contrast, generally exhibited a negative shift on PC1 relative to short-term galactose culture. Notably, the PC1 shift for mAKT-expressing cells was significantly larger than for either RFP-or MYC-expressing cells. To understand the proteins driving separation on PC1, we analyzed the PC1 loadings vector using 1D annotation enrichment using the Reactome Pathway Database (24, 25) . Among the enriched pathways, we found that two nonsense-mediated mRNA decay (NMD) pathways were enriched in positive PC1, in addition to several other mRNA-related pathways ( Fig.   4C and Supp. Fig. S5B ). To better understand how these pathways were regulated by galactose culture, we examined members of Nonsense-mediated mRNA decay (NMD) enhanced by the Exon Junction Complex (EJC), a surveillance pathway that eliminates mRNAs containing premature translation stop codons (26) . Visualization of these proteins on a heatmap revealed that their basal expression was low in mAKT-expressing cells cultured in glucose and that short-term galactose induced higher expression ( Fig. 4D and Supp. Fig. S5C ). In long-term galactose culture, the levels of NMD proteins were again reduced to low expression in mAKT-expressing cells. Taken together, this proteomic analysis suggests that mAKT-expressing cells in short-term galactose culture dramatically upregulated NMD.
mAKT but not RFP-or MYC-expressing cells exhibited oxidative stress in shortterm galactose culture.
In mammalian cells, activation of NMD can sensitize cells to oxidative stress (27) .
Because our metabolomic analysis (Figs. 3,4) demonstrated that mAKT-expressing cells
in short-term galactose culture upregulated glutathione metabolism, we hypothesized that AKT-expressing cells were dying from increased oxidative stress following the switch from glucose to galactose culture. We thus measured the levels of reactive oxygen species (ROS) using the fluorescent ROS probe DCF-DA. MCF-10A cells expressing either RFP, AKT promotes oxidative stress in galactose culture 12 mAKT, or MYC were switched from glucose to galactose culture for 3 h and ROS levels were measured by flow cytometry. In RFP-and MYC-expressing cells, the switch to galactose culture did not significantly alter ROS levels ( Fig. 5 ). In mAKT-expressing cells, however, 3 h of galactose culture increased the levels of ROS approximately ten-fold.
Thus, constitutively active AKT signaling but not MYC induced elevated ROS in galactose-cultured MCF-10A cells.
Galactose culture-induced cell death can be rescued by ROS scavengers.
Having identified that mAKT-expressing cells experience oxidative stress in shortterm galactose culture, we next tested whether ROS were functionally involved in the cell death caused by galactose culture. We cultured MCF-10A cells expressing either RFP, mAKT, or MYC in media without glucose, media with galactose, or media with galactose plus the ROS scavenger catalase. For MCF-10A cells expressing either RFP or mAKT, glucose starvation resulted in significant cell death ( Fig. 6A and Supporting Fig. S6A ).
Interestingly, cells expressing MYC were protected from glucose starvation-induced cell death, mirroring observations in normal human fibroblasts and glioma cells (6, 7) . In galactose culture, however, only MCF-10A cells expressing mAKT exhibited cell death.
In these mAKT-expressing cells, supplementation with the ROS scavenger catalase rescued cells from galactose culture-induced cell death. Thus, ROS induced by galactose culture are required for galactose culture-induced cell death.
Next, we sought to determine if our results in MCF-10A expressing mAKT were also reflected in breast cancer cell lines. We chose two cell lines reported to exhibit AKT promotes oxidative stress in galactose culture 13 constitutively active AKT signaling, MDA-MB-436 (MB436) and Hs578t (28, 29) . Western blotting confirmed that both cell lines exhibited AKT activation even after serum starvation ( Fig. 6B ). Next, we tested the effect of glucose starvation and galactose culture on these cell lines and found that both cell lines exhibited significant cell death upon glucose starvation and short-term galactose culture ( Fig. 6C and Supp. Fig. S6B ). In addition, for both cell lines, the ROS scavenger catalase rescued cells from galactose culture-induced cell death. Taken together, these results show that breast cancer cell lines with constitutively active AKT signaling experience ROS-mediated cell death when cultured in galactose medium, similar to our MCF-10A-mAKT cells.
DISCUSSION
The altered metabolism of tumors has long been proposed as a therapeutic target.
Defining the metabolic vulnerabilities induced by specific oncogenes is crucial for the design and stratification of therapeutics targeting tumor metabolism (8, 9) . Here, using the galactose culture system, which forces mammalian cells to rely on OXPHOS instead of glycolysis for energy generation (15) (16) (17) (18) (19) , we have uncovered a metabolic statedependent lethality, namely the restricted ability of cells with constitutively active PI3K/AKT signaling to switch between glycolysis and OXPHOS. Through multi-omic analysis, we identified that the galactose-induced cell death exhibited by mAKTexpressing cells was accompanied by increased glutathione metabolism ( Fig. 3 ) and increased expression of NMD proteins (Fig. 4) , a hallmark of sensitivity to oxidative stress.
Based on these results, we found that galactose-induced cell death required ROS, both in MCF-10A cells expressing mAKT and in breast cancer cell lines with activated PI3K/AKT signaling ( Fig. 5-6 ). Taken together, these results reveal a novel metabolic state vulnerability induced by PI3K/AKT signaling.
Our findings in MCF-10A, a non-tumorigenic but immortalized breast cancer cell line, confirm reports that constitutive activation of PI3K/AKT signaling forces cells to rely on aerobic glycolysis (14, 20) . Stable isotope tracing with [U-13 C]-L-glutamine confirmed that these cells exhibit less glutamine anaplerosis than either RFP-or MYC-expressing cells when cultured in glucose ( Fig. 2A, B) . Interestingly, MCF-10A cells expressing the negative control RFP were sensitive to glucose deprivation, and mAKT expression did not further sensitize cells to glucose starvation (Fig. 6A ). However, RFP-expressing cells were able to switch from glycolysis to aerobic respiration, as evidenced by their survival and growth in galactose media (Figs. 1, 6 ). mAKT-expressing cells, in contrast, were initially unable to metabolize galactose, leading to ROS-mediated cell death even though PI3K/AKT activation can increase resistance to oxidative stress by upregulating glutathione biosynthesis (30) . In addition, our observation that MYC did not sensitize MCF-10A cells to galactose culture supports previous reports that AKT and MYC differentially alter metabolism, including the creation of metabolic vulnerabilities in glycolysis and mitochondrial bioenergetics, respectively (13, 14) . Similarly, our data confirm that MYC activation protects against glucose deprivation (6,7), though MYC expression in MCF-10A cells did not exhibit substantial increases in oxidative metabolism relative to RFP-expressing cells as has been seen in other cell types (31) . Together, the differential sensitivity of AKT-and MYC-expressing cells suggests that these oncogenes alter metabolism through distinct mechanisms even though both can upregulate aerobic glycolysis (11, 12, 32) .
Although mAKT-expressing cells initially die in galactose culture, these cells recommence proliferation after ~15 days. At present, it is not known if this represents metabolic remodeling to process galactose (i.e., acquired resistance) or the emergence of a pre-existing sub-population of galactose-metabolizing cells (i.e., clonal selection). It is notable, however, that the AKT-expressing cells proliferating in galactose exhibit slower growth relative to glucose than either RFP-or MYC-expressing cells (Fig. 1B) . Thus, even the "galactose-resistant" mAKT-expressing cells exhibit a disadvantage in oxidative culture, which may explain why proliferating mAKT cells exhibit a substantially different galactose metabolism than RFP-or MYC-expressing cells ( Fig. 2E-F) . Notably, because long-term culture in galactose did not alter AKT expression or phosphorylation, the changes that enable proliferation of mAKT-expressing cells in galactose must occur downstream of AKT itself (Fig. 1D) . These changes could include increased mitochondrial content and aerobic metabolism, as has been observed when human myotubes, which have low mitochondrial oxidative potential, are cultured in galactose (33, 34) . Regardless, the fact that mAKT cells reliably and rapidly demonstrates resistance to galactose suggests that eradication of tumors with constitutive PI3K/AKT signaling will require the therapeutic targeting of another, compensatory pathway to prevent re-emergence.
Notably, at this time, we have been unable to generate galactose-resistant clones of either MB436 or Hs578t, suggesting that these breast cancer cells harbor oncogenic lesions in addition to PI3K/AKT signaling that more permanently restrict the flexibility to utilize OXPHOS.
Another possible mechanism by which mAKT-expressing cells adapt to galactose culture might be through suppression of NMD (Fig. 4) . In general, oxidative stress suppresses NMD in order to enhance the ability of cells to survive ROS toxicity (26, 27) .
However, when NMD is activated, cells become more sensitive to oxidative stress (27) .
Thus, the galactose-induced cell death of mAKT-expressing may be due to increased ROS levels coinciding with increased sensitivity to oxidative stress due to NMD upregulation. In fact, there may exist a direct link between AKT signaling and NMD upregulation, as insulin signaling in HeLa cells upregulates NMD through increased binding of UPF1, the master regulator of NMD, to mRNA transcripts (35) . In our MCF-10A-AKT and breast cancer cell lines, the mechanisms by which AKT signaling in galactose induces the upregulation of NMD proteins are currently under investigation.
In summary, the deregulation of PI3K/AKT and MYC in breast cancer motivates further research into how these oncogenes generate oncogene-dependent metabolic vulnerabilities. Like AKT and MYC, many other frequently altered oncogenes including BRAF (36), ERBB2 (37), KRAS (38, 39) , and VHL (40) alter the balance between glycolysis and OXPHOS. However, it remains to be tested whether these oncogenes will affect the flexibility of cells to shift between respiration and OXPHOS as does AKT.
Regardless of the oncogene, it will be crucial to understand how oncogenic events define the response to fluctuations in nutrient availability, oxygen tension, and pH within the tumor microenvironment (41) . In addition, given the flexibility and adaptability of cancer metabolism, inhibition of a single molecular target (e.g., glycolysis in tumors with hyperactivated AKT signaling) may not prove sufficient for tumor eradication. As such, combinational therapies that generate synthetic lethality in tumors also need to be investigated in the context of oncogene dependence (42) (43) (44) . Taken together, our findings highlight that the importance of oncogene-dependent metabolic vulnerabilities in cancer cells and suggest that therapies targeting tumor metabolism will need to be appropriately paired with tumor genetic profiles.
MATERIALS AND METHODS
Cell culture:
MCF-10A human mammary epithelial cells were obtained from American Type 
Retroviral infection:
RFP, myristoylated AKT, and MYC were cloned into the pDS-FB-neo retroviral vector and verified by Sanger sequencing. Retrovirus was prepared in 293T cells by cotransfection with viral packaging plasmids. Following infection, MCF-10A cells were selected with 1 mg/ml G418. Following selection, cells were maintained in media with 500 µg/ml G418.
Reactive oxygen species measurement:
MCF-10A were treated in respective media for 3 h. Hydrogen peroxide (1 mM AKT promotes oxidative stress in galactose culture 20
LC-MS Metabolomics:
MCF-10A cells were plated on 6-well plates at the density of 7,333 cells/cm 2 . After 24 h, media was removed, cells were washed twice with 2 mL of PBS, and 1 mL of media was added to cells. Media contained either [U-13 C]-L-glutamine or [U-13 C]-galactose (Cambridge Isotope Laboratories). After 24 h, the culture plates were cooled on ice, media was aspirated, and the cells were washed with 1 mL of cold ammonium acetate.
Upon aspirating the ammonium acetate, metabolites were extracted with 1 mL of -80˚C methanol. The methanol cell suspension was scraped and transferred to Eppendorf tubes, and the cell suspension was centrifuged at 4˚C. The supernatants was transferred to a new Eppendorf tubes, and the pellet was re-extracted with another 350 µL of -80˚C methanol. The second methanol extraction was spun down, and the supernatant was pooled with the first extraction. Metabolites were speed-vac dried, resuspended in LC-MS grade water, and sent for LC-MS analysis.
Samples were randomized and analyzed on a Q Exactive Plus hybrid quadrupole-Orbitrap mass spectrometer coupled to an UltiMate 3000 UHPLC system (Thermo Scientific). The mass spectrometer was run in polarity switching mode (+3.00 kV/-2.25 kV) with an m/z window ranging from 65 to 975. Mobile phase A was 5 mM NH4AcO, pH 9.9, and mobile phase B was acetonitrile. Metabolites were separated on a Luna 3 µm NH2 100 Å (150 × 2.0 mm) column (Phenomenex). The flowrate was 300 µL/min, and the gradient was from 15% A to 95% A in 18 min, followed by an isocratic step for 9 min and re-equilibration for 7 min. All samples were run in biological triplicate. Metabolites were detected and quantified as area under the curve based on retention time and accurate AKT promotes oxidative stress in galactose culture 21 mass (≤ 8 ppm) using the TraceFinder 3.3 (Thermo Scientific) software. Raw data were corrected for naturally occurring 13 C abundance (45) . Intracellular data was normalized to the cell number at the time of extraction.
LC-MS Proteomics:
MCF-10A cells dishes were placed on ice and washed with PBS. Cells were then scraped and pelleted by centrifugation. The cell pellets were lysed by probe sonication in 8 M urea (pH 7.5), 50 mM Tris, 1 mM activated sodium vanadate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, and 100 mM sodium phosphate. The above procedures were performed in 0-4˚C. Insoluble cell debris were filtered by 0.22 um syringe filter. Protein concentration was measured by BCA assay (Pierce, PI23227).
Lysates were reduced with 5 mM DTT, alkylated with 25 mM iodoacetamide, quenched with 10 mM DTT, and acidified to pH 2 with 5% trifluoracetic acid. Proteins were then digested to peptides using a 1:100 trypsin to lysate ratio by weight. Tryptic peptides were desalted by reverse phase C18 StageTips and eluted with 30% acetonitrile. The eluents were vacuumed dried, and 250 ng/injection was submitted to LC-MS. We performed two independent biological replicates, and each experiment were subjected to two technical LC-MS injections.
The samples were randomized and injected into an Easy 1200 nanoLC ultra highperformance liquid chromatography coupled with a Q Exactive quadruple orbitrap mass spectrometry (Thermo Fisher). Peptides were separated by a reverse-phase analytical column (PepMap RSLC C18, 2 µm, 100Å, 75 µm X 25 cm). Flow rate was set to 300 AKT promotes oxidative stress in galactose culture 22 nL/min at a gradient from 3% buffer B (0.1% formic acid, 80% acetonitrile) to 38% B in 110 min, followed by a 10-minute washing step to 85% B. The maximum pressure was set to 1,180 bar and column temperature was maintained at 50˚C. All samples were run in technical duplicate. Peptides separated by the column were ionized at 2. Dynamic modifications were set to oxidation on methionine (M, +15.995 Da) and acetylation on protein N-terminus (+42.011 Da). Carbamidomethylation on cysteine residues (C, +57.021 Da) was set as a fixed modification. The maximum parental mass error was set to 10 ppm, and the MS/MS mass tolerance was set to 0.02 Da. The false discovery threshold was set strictly to 0.01 using the Percolator Node validated by q-value.
The relative abundance of parental peptides was calculated by integration of the area under the curve of the MS1 peaks using the Minora LFQ node.
DATA AVAILABILITY
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (48) with the dataset identifier PXD015122 (reviewer username: reviewer74490@ebi.ac.uk, reviewer password: X1dvWm5c). Metabolite pool sizes were filtered for ANOVA p-value < 0.5, and clustered using one minus the Pearson correlation and average linkage. Samples clustered by media type (e.g., Glc) rather than by oncogenes (e.g., RFP). Metabolites are colored at right of the heatmap according to their metabolic pathways. Red and blue denote higher and lower abundance, respectively, from samples run in biological triplicate. 
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